[1] |
Hess DB, Asrani SG, Bhide MG, et al. Macular and retinal nerve fiber layer analysis of normal and glaucomatous eyes in children using optical coherence tomography[J]. Am J Ophthalmol,2005,139(3):509-517.
|
[2] |
Hood DC, Raza AS. Method for comparing visual field defect stolocal RNFL and RGC damage seen on frequency domain OCT in patients with glancoma[J]. Biomed Opt Express,2011, 2(5):1097-1105.
|
[3] |
Garas A, Vargha P, Holló G. Diagnostic accuracy of nerve fibre layer macular thickness and optic disc measurements made with the RTVue-100 optical coherence tomograph to detect glaucoma[J]. Eye (Lond),2011,25(1):57-65.
|
[4] |
刘义戈,刘华. 光学相干断层扫描在眼科临床应用的研究进展[J]. 医学综述,2007,13(24):2014-2016.
|
[5] |
Vizzeri G, Weinreb RN, Gonzalez-Garcia AO, et al. Agreement between spectral-domain and time-domain OCT for measuring RNFL thickness[J]. Br J Ophthalmol,2009,93(6):775-781.
|
[6] |
Tehrani R, Ostrowski RA, Hariman R, et al. Ocular toxicity of hydroxychloroquine[J]. Semin Ophthalmol,2008,23(3):201-209.
|
[7] |
Ingster-Moati I, Bui Quoc E, Crochet M, et al. Severe chloroquine- and hydroxychloroquine-induced retinopathy[J]. J Fr Ophtalmol,2006,29(6):642-650.
|
[8] |
余碧娥,方丽. 羟氯喹的眼科不良反应分析[J]. 中国新药与临床杂志,2001,20(3):235-236.
|
[9] |
Pasadhika S, Fishman GA. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures[J]. Eye,2010,24(2):340-346.
|
[10] |
Korah S, Kuriakose T. Optical coherence tomography in a patient with chloroquine-induced maculopathy[J]. Indian J Ophthalmol,2008,56(6):511-513.
|
[11] |
Marschall S, Sander B, Mogensen M, et al. Optical coherence tomography curent technology and applications in clinical an biomedteal research[J]. Anal Bioanal Chem,2011,400(9):2699-2720.
|
[12] |
李春,刘恩生,穆荣,等. 羟氯喹所致视网膜病变的临床分析[J]. 药物不良反应杂志,2010,12(1):21-25.
|
[13] |
Blomquist PH, Chundru RK. Screening for hydroxychloroquine toxicity by Texas ophthalmologists[J]. J Rheum,2002,29(8):1665-1670.
|
[14] |
Marmor MF. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG[J]. Am J Ophthalmol,2005, 140(5):894-895.
|
[15] |
Marmor MF, Carr RE, Easterbrook M, et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology[J]. Ophthalmology,2002,109(7):1377-1382.
|
[16] |
Lai TY, Chan WM, Li H, et al. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy[J]. Am J Ophthalmol,2005,140(5):794-807.
|